Baricitinib reduces 30‐day mortality in older adults with moderate‐to‐severe COVID ‐19 pneumonia-Reference-Cited by-同舟云学术

Baricitinib reduces 30‐day mortality in older adults with moderate‐to‐severe COVID ‐19 pneumonia

Published:2021-07-09 Issue:10 Volume:69 Page:2752-2758
ISSN:0002-8614
Container-title:Journal of the American Geriatrics Society
language:en
Short-container-title:J Am Geriatr Soc

Author:

Abizanda Pedro¹²³^ORCID,Calbo Mayo Juan María⁴,Mas Romero Marta¹,Cortés Zamora Elisa Belén¹²,Tabernero Sahuquillo María Teresa¹,Romero Rizos Luis¹²³,Sánchez‐Jurado Pedro Manuel¹²³,Sánchez‐Nievas Ginés⁵,Campayo Escolano Carlos⁴,Ochoa Serrano Alba⁴,Sánchez‐Flor Alfaro Victoria¹,López Bru Rita¹,Gómez Ballesteros Cristina¹,Caldevilla Bernardo David⁶,Callejas González Francisco Javier⁷,Andrés‐Pretel Fernando⁸,Lauschke Volker Martin⁹,Stebbing Justin¹⁰

Affiliation:

1. Department of Geriatrics Complejo Hospitalario Universitario de Albacete Albacete Spain

2. CIBERFES Ministerio de Economía y Competitividad Madrid Spain

3. Facultad de Medicina Universidad de Castilla‐La Mancha Albacete Spain

4. Department of Internal Medicine Complejo Hospitalario Universitario de Albacete Albacete Spain

5. Department of Rheumatology Complejo Hospitalario Universitario de Albacete Albacete Spain

6. Department of Radiology Complejo Hospitalario Universitario of Albacete Albacete Spain

7. Department of Neumology Complejo Hospitalario Universitario of Albacete Albacete Spain

8. Department of Statistics Foundation of the National Paraplegics Hospital of Toledo Toledo Spain

9. Department of Physiology and Pharmacology Karolinska Institutet Stockholm Sweden

10. Department of Surgery and Cancer, Imperial College Hammersmith Hospital, ICTEM Building London UK

Funder

Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Geriatrics and Gerontology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgs.17357

Reference24 articles.

1. WHO must prioritise the needs of older people in its response to the covid-19 pandemic

2. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

3. Case‐fatality rate and characteristics of patients dying in relation to COVID‐19 in Italy;Onder G;JAMA,2020

4. WHO–China Joint Mission.Report of the WHO‐China Joint Mission on Corona Virus Disease 2019 (COVID‐19) (pdf); 2020.https://www.who.int/docs/default‐source/coronaviruse/who‐china‐joint‐mission‐on‐covid‐19‐final‐report.pdf. Accessed April 25 2021.

5. Age and frailty are independently associated with increased COVID-19 mortality and increased care needs in survivors: results of an international multi-centre study

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies;International Journal of Molecular Sciences;2024-07-26

2. Clinical Manifestations and Outcomes of Older Patients with COVID-19: A Comprehensive Review;Tuberculosis and Respiratory Diseases;2024-04-01

3. Secondary infections and long-term outcomes among hospitalized elderly and non-elderly patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and treated with baricitinib: a comparative study from the national centre of Hungary;GeroScience;2024-02-17

4. Computational insight of repurpose drug for treatment of COVID-19: a CDFT approach;Theoretical Chemistry Accounts;2023-12-27

5. Efficacy and safety of baricitinib in patients with severe COVID-19: A systematic review and meta-analysis;Medicine;2023-12-01